Skip to main content

Zambia

Tariffs

Download data

3002.41 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine

1 tariff line

3002.41 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine
HS code Product MFN COMESA-FTA ZMB-ERI ZMB-ETH ZMB-ZAF SADC
3002.41.00 Vaccines for human medicine 0% 0% 0% 0% 0% 0%

Showing 1–1 of 1

HS 3002.41.00

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine

Section VI · Products of the chemical & allied industries › Ch 30 Pharmaceutical products › 30.02 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified

Close

Applied duty rates

  • 0% MFN applied rate
  • 0% COMESA-FTA preferential rate
  • 0% ZMB-ERI preferential rate
  • 0% ZMB-ETH preferential rate
  • 0% ZMB-ZAF preferential rate
  • 0% SADC preferential rate
Exports | US$ thousand
  • To the world
  • Within the Commonwealth
Show data
YearTo the worldWithin the Commonwealth
2020$0$0
2021$0$0
2022$1,257$0
2023$2,199$2,199
2024$2,221$2,221
2025$1,464$1,464
Imports | US$ thousand
  • From the world
  • Within the Commonwealth
Show data
YearFrom the worldWithin the Commonwealth
2020$0$0
2021$0$0
2022$132,079$4,306
2023$37,095$13,128
2024$39,481$18,699
2025$24,115$9,739

Pilot countries

Each country has its own profile: tariff regime, export requirements, a market snapshot and links to official national portals. 

See all countries

Share this page with